Parabolic Drugs Ltd

BSE : PARABDRUGS25 Jan 2021

Pharmaceuticals

₹

0.00 (0.00%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Parabolic Drugs Ltd

Parabolic Drugs Ltd

Pharmaceuticals

BSE : PARABDRUGS25 Jan 2021

₹

0.00 (0.00%)

OverviewFundamentals

Corporate action

Peer comparison

Cash flow

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
14-Aug-2012	D	Parabolic Drugs Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 14, 2012, inter alia, has recommend dividend @ Rs. 0.25 per share on fully paid equity shares of the Company for the year 2011-2012.	24-Sep-2012
16-Aug-2011	D	Parabolic Drugs Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 13, 20111, inter alia, has recommended dividend @ Rs. 0.50 per share on fully paid up equity shares of the Company for the year 2010-2011.	19-Sep-2011
04-Aug-2021	BC	Trading Members of the Exchange are hereby informed that pursuant to resolution plan approved by Hon'ble National Company Law Tribunal (NCLT), Chandigarh Bench vide its order dated January 12, 2021,	11-Aug-2021
04-Aug-2021	BC	Sub : Delisting -Parabolic Drugs Limited It is hereby notified that the following security shall be withdrawn (delisted) w.e.f. August 11, 2021. Symbol PARABDRUGS Company Name Parabolic Dr	11-Aug-2021
05-Feb-2021	BC	Parabolic Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2021 ,inter alia, to consider and approve Un-Audited Financial Results for the Quar	11-Feb-2021
25-Jan-2021	BC	Resolution Plan -Extinguishment of equity anddelisting	29-Jan-2021
25-Jan-2021	BC	SUB. : - Resolution Plan - suspension of trading in equity shares of Parabolic Drugs Ltd (Scrip Code 533211). Trading members of the Exchange are hereby informed that, Parabolic Drugs Ltd has fi	28-Jan-2021

No Rights has been declared by PARABDRUGS

Book Closure

Record Date	Split Date	Purpose
11-Aug-2021	-	Trading Members of the Exchange are hereby informed that pursuant to resolution plan approved by Hon'ble National Company Law Tribunal (NCLT), Chandigarh Bench vide its order dated January 12, 2021,
11-Aug-2021	-	Sub : Delisting -Parabolic Drugs Limited It is hereby notified that the following security shall be withdrawn (delisted) w.e.f. August 11, 2021. Symbol PARABDRUGS Company Name Parabolic Dr
11-Feb-2021	-	Parabolic Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2021 ,inter alia, to consider and approve Un-Audited Financial Results for the Quar
29-Jan-2021	-	Resolution Plan -Extinguishment of equity anddelisting
28-Jan-2021	-	SUB. : - Resolution Plan - suspension of trading in equity shares of Parabolic Drugs Ltd (Scrip Code 533211). Trading members of the Exchange are hereby informed that, Parabolic Drugs Ltd has fi

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Parabolic Drugs Ltd ₹5.70(0.00/0.00%)	5.70	+0.00	35.28	141.53	0.00	-0.04
Bliss GVS Pharma Ltd ₹159.20(-4.50/-2.75%)	159.20	-4.50	1,724.85	24.25	21.34	1.68
Amrutanjan Health Care Ltd ₹677.70(-26.20/-3.72%)	677.70	-26.20	2,035.02	17.78	42.82	6.83
Astrazeneca Pharma India Ltd ₹6,731.95(-298.40/-4.24%)	6,731.95	-298.40	17,575.88	13.50	136.54	25.87
Abbott India Ltd ₹27,763.95(-491.60/-1.74%)	27,763.95	-491.60	60,043.04	7.81	46.74	17.05
Ambalal Sarabhai Enterprises Ltd ₹50.49(-0.93/-1.81%)	50.49	-0.93	394.05	-1.08	44.71	8.74

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014
Cash and Cash Equivalents at Beginning of the year	0.60	0.64	3.02	5.99	12.10
Net Cash from Operating Activities	3.02	1.65	89.58	-3.94	27.94
Net Cash Used In Investing Activities	0.86	0.50	1.39	-15.89	-29.99
Net Cash Used In Financing Activities	-3.70	-2.19	-93.36	16.87	-4.06
Net Inc./Dec In Cash And Cash Equivalents	0.18	-0.04	-2.39	-2.96	-6.11
Cash And Cash Equivalents At End Of The Year	0.78	0.60	0.64	3.02	5.99

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

37.79%

FII Shareholding

8.06%

DII Shareholding

0.57%

Public Shareholding

53.57%

**Promoter pledged shareholding 37.79%

About Parabolic Drugs Ltd

Parabolic Drugs Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 35.28 crores. It has reported a sales of Rs. 0 crores and a net profit of Rs. -6.05 crores for the quarter ended December 2018. The company management includes , Pranav Gupta,Vineet Gupta,Jagjit Singh Chahal,Vandana Singla,Sanjeev Kumar (Parabolic Drugs Ltd) among others.

Chairman

Registered office

SCO 186-187 2nd Floor,Sector 8c,Chandigarh,Chandigarh,160008

FAX :

Background

Incorporation Year1996

Face Value₹10

Market Lot1